XML 67 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Investments in Joint Ventures - Intrexon T1D Partners - Additional Information (Details)
1 Months Ended
Nov. 30, 2018
USD ($)
shares
Mar. 31, 2016
USD ($)
Mar. 31, 2019
USD ($)
board_seat
Dec. 31, 2018
USD ($)
Oct. 31, 2018
USD ($)
Schedule of Equity Method Investments [Line Items]          
Deferred revenue     $ 71,191,000 $ 69,764,000  
Collaboration and licensing agreements          
Schedule of Equity Method Investments [Line Items]          
Deferred revenue     $ 65,135,000 $ 63,284,000  
Intrexon T1D Partners, LLC          
Schedule of Equity Method Investments [Line Items]          
Membership interest 100.00% 50.00%      
Maximum additional capital contribution committed   $ 5,000,000      
Total number of seats on the joint venture's governing board, internally selected | board_seat     2    
Total number of seats on the joint venture's governing board, externally selected | board_seat     3    
Stock issued during period, shares, purchase of assets (in shares) | shares 1,933,737        
Stock issued during period, value, purchase of assets $ 18,970,000        
Deferred revenue         $ 8,517,000
Write-off of in-process research and development acquired in asset acquisition $ 10,453,000        
Intrexon T1D Partners, LLC | Investors          
Schedule of Equity Method Investments [Line Items]          
Membership interest   50.00%      
Capital contributions   $ 10,000,000      
Maximum additional capital contribution committed   5,000,000      
Intrexon T1D Partners, LLC | Collaboration and licensing agreements          
Schedule of Equity Method Investments [Line Items]          
Collaborative arrangement consideration received, value   $ 10,000,000